111 Capital’s Twist Bioscience TWST Stock Holding History

111 Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,400	Closed	-$235K	–	691
2025 Q2	$235K	Buy	+6,400	New	+$221K	0.04%	420

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

111 Capital's TWST Position: Q3 2025 in Review

111 Capital sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 6,400 shares — an estimated $235K sold.

111 Capital first reported a position in TWST in Q2 2025 and held it in 1 quarter. The position peaked at $235K in Q2 2025. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

111 Capital reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
111 Capital sold 6,400 Twist Bioscience shares in Q3 2025, an estimated $235K.
111 Capital first reported a position in Twist Bioscience in Q2 2025 and held it in 1 quarter.
111 Capital's Twist Bioscience position peaked at $235K in Q2 2025.
238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.